Skip to main content

Table 1 Characteristics of CHD cases and controls and stroke cases and controls from the WHI postmenopausal HT trials of estrogen plus progestin (E + P) and estrogen-alone (E-alone): Mean ± SE for continuous baseline covariates, N (%) for categorical baseline covariates

From: Proteomic risk markers for coronary heart disease and stroke: validation and mediation of randomized trial hormone therapy effects on these diseases

CHD

 

E + P

E-alone

 

Cases

Controls

P valuea

Cases

Controls

P valuea

N

206

202

 

152

150

 

Ageb (years)

66.61 (7.55)

66.49 (7.44)

0.87

67.55 (6.01)

67.58 (6.03)

0.96

BMI (kg/m2)

28.81 (5.61)

27.57 (5.38)

0.02

30.21 (5.71)

29.49 (5.86)

0.28

Systolic BP (mmHg)

135.04 (18.62)

130.32 (17.85)

0.01

138.48 (18.50)

129.75 (17.77)

<.0001

Diastolic BP (mmHg)

77.04 (10.26)

75.39 (8.83)

0.08

76.29 (10.81)

74.56 (8.81)

0.13

Race (%)

  

0.77

  

0.66

White

185 (91.6)

180 (89.6)

 

117 (78.0)

118 (79.2)

 

Black

11 (5.4)

13 (6.5)

 

26 (17.3)

27 (18.1)

 

Other

3 (3.0)

8 (4.0)

 

7 (4.7)

4 (2.7)

 

Smoking (%)

  

0.001

  

0.11

Never

92 (46.0)

114 (57.0)

 

70 (46.7)

79 (53.4)

 

Past

68 (34.0)

72 (36.0)

 

55 (36.7)

56 (37.8)

 

Current

40 (20.0)

14 (7.0)

 

25 (16.7)

13 (8.8)

 

History of CHDb (%)

  

1

  

1

Yes

19 (9.2)

19 (9.4)

 

21 (13.8)

21 (14.0)

 

No

187 (90.8)

183 (90.6)

 

131 (86.2)

129 (86.0)

 

Treated diabetes (%)

  

0.04

  

0.0003

Yes

29 (14.1)

15 (7.4)

 

39 (25.7)

14 (9.3)

 

No

177 (85.9)

187 (92.6)

 

113 (74.3)

136 (90.7)

 

Prior use of HT (%)

  

0.04

  

0.13

Never

152 (73.8)

152 (75.2)

 

96 (63.2)

97 (64.7)

 

Past

48 (23.3)

39 (19.3)

 

48 (31.6)

37 (24.7)

 

Current

6 (2.9)

11 (5.4)

 

8 (5.3)

16 (10.7)

 

Stroke

 

E + P

E-alone

 

Cases

Controls

P value a

Cases

Controls

P value a

N

182

176

 

180

170

 

Ageb (years)

67.90 (6.61)

67.86 (6.61)

0.96

67.56 (6.34)

67.43 (6.49)

0.85

BMI (kg/m2)

28.04 (4.94)

27.81 (6.26)

0.70

29.66 (5.42)

28.55 (5.39)

0.06

Systolic BP (mmHg)

137.82 (19.79)

128.24 (15.20)

<.0001

139.93 (19.34)

132.87 (17.51)

0.0004

Diastolic BP (mmHg)

76.73 (10.43)

73.93 (9.35)

0.008

77.99 (9.29)

76.45 (9.21)

0.12

Race (%)

  

0.68

  

0.98

White

156 (87.6)

156 (90.2)

 

134 (74.4)

126 (75.4)

 

Black

14 (7.9)

12 (6.9)

 

30 (16.7)

27 (16.2)

 

Other

8 (4.5)

5 (2.9)

 

16 (8.9)

14 (8.4)

 

Smoking (%)

  

0.002

  

0.98

Never

77 (42.5)

102 (59.3)

 

92 (52.9)

60 (53.9)

 

Past

74 (40.9)

58 (33.7)

 

68 (39.1)

64 (38.3)

 

Current

30 (16.6)

12 (7.0)

 

14 (8.0)

13 (7.8)

 

History of strokeb (%)

  

1

  

1

Yes

5 (2.7)

4 (2.3)

 

9 (5.0)

9 (5.3)

 

No

177 (97.3)

172 (97.7)

 

171 (95.0)

161 (94.7)

 

Treated diabetes (%)

  

0.005

  

0.05

Yes

20 (11.0)

5 (2.8)

 

28 (15.6)

14 (8.2)

 

No

162 (89.0)

171 (97.2)

 

152 (84.4)

156 (91.8)

 

Prior use of HT (%)

  

0.50

  

0.40

Never

135 (74.2)

129 (73.3)

 

92 (51.1)

87 (51.2)

 

Past

42 (23.1)

38 (21.6)

 

75 (41.7)

64 (37.6)

 

Current

5 (2.7)

9 (5.1)

 

13 (7.2)

19 (11.2)

 
  1. aP value from chi-square test.
  2. bCase-control matching variables.
  3. BMI, body mass index; BP, blood pressure.